Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Graves' hyperthyroidism undergoing radioiodine therapy: a randomized controlled study

European Journal of Endocrinology
D TaiebKarine Baumstarck

Abstract

While radioiodine therapy is commonly used for treating Graves' disease, a prolonged and clinical hypothyroidism may result in disabling symptoms leading to deterioration of quality of life (QoL) of patients. Introducing levothyroxine (LT4) treatment in the early post-therapeutic period may be an interesting approach to limit this phenomenon. A multicenter, prospective, open-label randomized controlled trial enrolled 94 patients with Graves' hyperthyroidism randomly assigned to the experimental group (n=46) (group A: early prophylactic LT4 treatment) or the control group (n=48) (group B: standard follow-up). The primary endpoint was the 6-month QoL. The secondary endpoints were other QoL scores such as Graves' ophthalmopathy (GO) outcomes, thyroid function tests and safety. The primary endpoint at 6 months was achieved: the mental composite score (MCS) of Short Form 36 (SF-36) was significantly higher in group A compared to group B (P=0.009). Four other dimension scores of the SF-36 and four dimension scores of the thyroid-specific patient-reported outcome (ThyPRO) significantly differed between the two groups, indicating better QoL in group A. After adjustment for variables, the early LT4 administration strategy was found as a...Continue Reading

References

Jun 25, 1992·The New England Journal of Medicine·L TallstedtA Taube
Apr 11, 1992·International Journal of Cancer. Journal International Du Cancer·P HallK Wiklund
Oct 1, 1994·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·R JaeschkeH C Gerstein
Aug 1, 1998·JAMA : the Journal of the American Medical Association·E RonJ D Boice
Nov 17, 1998·Journal of Clinical Epidemiology·A LeplègeT V Perneger
Jun 1, 2002·European Journal of Endocrinology·Caroline TerweeWilmar Wiersinga
Oct 23, 2002·Clinical Endocrinology·Paul W Ladenson
Dec 17, 2002·Current Opinion in Pharmacology·John P Walsh
Mar 12, 2003·The Journal of Clinical Endocrinology and Metabolism·Judith E Kalinyak, I Ross McDougall
Mar 12, 2003·The Journal of Clinical Endocrinology and Metabolism·William D LeslieElizabeth A Cowden
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Oct 15, 2003·The Journal of Clinical Endocrinology and Metabolism·Michael M KaplanArthur B Schneider
Dec 13, 2003·The Journal of Clinical Endocrinology and Metabolism·Jiri Horacek, Jayne A Franklyn
Mar 1, 2005·Multiple Sclerosis : Clinical and Laboratory Research·D KosJ Jansa
Sep 29, 2005·European Journal of Endocrinology·Prakash AbrahamJohn S Bevan
Jul 15, 2006·Thyroid : Official Journal of the American Thyroid Association·N N PatelM P J Vanderpump
May 1, 2007·Clinical Endocrinology·Anthony P Weetman
Apr 26, 2008·BMJ : British Medical Journal·Gordon H GuyattUNKNOWN GRADE Working Group
Jun 14, 2008·The New England Journal of Medicine·Gregory A Brent
Nov 18, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Andrew BottomleyLily Claassens
Sep 3, 2009·The Journal of Clinical Endocrinology and Metabolism·Frank TräiskUNKNOWN Thyroid Study Group of TT 96
Oct 3, 2009·European Journal of Endocrinology·Torquil WattUlla Feldt-Rasmussen
Sep 4, 2012·World Journal of Nuclear Medicine·J F NwatsockO Mundler
Feb 28, 2013·JAMA : the Journal of the American Medical Association·Melanie CalvertUNKNOWN CONSORT PRO Group
Oct 16, 2013·Nature Reviews. Endocrinology·Luigi Bartalena

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.